Across TCGA pan-cancer cohorts, RN7SL555P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RN7SL555P’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL555P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL555P is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.
COAD are the cancer types where RN7SL555P tumor–normal differential expression is most reproducible.